Delivered as a Hybrid Event|September 18-21, 2023, Boston Convention and Exhibition Center
THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS
Access the science, technologies and contacts you need to improve efficiencies across all phases of biopharmaceutical development and production.
2700+ Global Attendees · 200+ Exhibitors · 150+ Scientific Posters · 8 Conference Tracks
Learn from the brightest minds in bioprocessing
The BPI US 2023 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Access Novel Science Across the Entire Bioprocessing Spectrum
Our BPI 2023 agenda includes 8 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. Your registration provides access to the presentations across all 8 tracks, allowing you to create an agenda tailored specifically for your needs. Your conference pass provides on-demand access to the main conference presentation recordings for a full 12 months after the in-person event concludes.
Manufacturing Strategy & Bioprocessing 4.0
Apply digital technologies, artificial intelligence and machine learning to increase manufacturing efficiency through smart and data-driven bioprocessing.
Cell Culture & Upstream Processing
Optimize speed and quality during upstream processing through real-time monitoring, process development and acceleration through technology.
Recovery & Purification
Leverage predictive approaches, prior knowledge, digital applications and data while applying transformative technologies to overcome bottlenecks, maximize quality and control, and enable next generation downstream processing for emerging modalities.
Analytical & Quality
Achieve a high-quality product using optimal analytical strategies, PAT and process development whilst reducing timelines.
Get to grips with raw materials, cryopreservation, and logistical requirements for seamless end-to-end supply chains.
Gene Edited Ex Vivo Cell Therapy
Overcome autologous and allogeneic manufacturing challenges with novel modalities, gene editing and more.
In Vivo Gene Therapy
Increase speed, consistency, scalability, and flexibility in gene therapy manufacturing.
New for 2023! Well Characterized Biologics & Biological Assays
Gain practical advice from case studies, FDA & regulatory leaders to accelerate your biologics & novel modalities/molecules to market.
Get the Latest Event Updates
Attend the Industry's Leading Bioprocessing Event
Join 2700+ global bioprocessing professionals at this year's event as you learn about today's innovative science and technologies designed to accelerate your biologics and novel products to market.
Lars Pampel, Ph.D., Head, Process Sciences, Technical Development, New Biological Entities, Novartis, Switzerland
“BPI brings leading thoughts and discussion to a balanced audience of scientists and decision makers.”
CONNECT WITH KEY BUYERS BY BECOMING A BPI SPONSOR/EXHIBITOR
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals in today's virtual environment.
Contact Jennifer Wickett: JWickett@informaconnectls.com | +1-212-600-3452